COVID-19 Liver Damage Study Uncovers New Insights into Long Term Effects

Medical News: The global COVID-19 pandemic has primarily been associated with severe respiratory complications, but researchers have been uncovering more evidence that the virus affects multiple organs, including the liver. A groundbreaking new study provides fresh insights into how COVID-19 alters liver function at a cellular level, potentially leading to long-term complications. Conducted by a team of scientists from institutions including Harvard Medical School, the Broad Institute of MIT and Harvard, Columbia University Irving Medical Center, and the University of Toronto, this research sheds light on the previously unrecognized impact of the virus on liver cells.

COVID-19 Liver Damage Study Uncovers New Insights into Long Term Effects

This Medical News report explores the findings of a detailed study that utilized advanced single-cell and spatial transcriptomic techniques to examine liver tissues from COVID-19 patients. The researchers identified critical cellular changes, including hepatocyte damage, fibrosis-related pathways, and abnormal immune responses. The study offers a new understanding of post-COVID-19 liver conditions and could help in developing targeted treatment strategies for affected patients.
 
How the Study Was Conducted
The research team analyzed liver samples from 17 deceased COVID-19 patients who had been hospitalized in multiple medical centers in the United States. These samples were compared to healthy liver samples from four individuals who had no history of COVID-19. To conduct this investigation, the team employed single-nucleus RNA sequencing (snRNA-seq) and spatial transcriptomics, which allowed them to map and analyze cellular changes with a high degree of precision.
Their approach enabled the identification of specific liver cells that had been affected by the virus and revealed molecular pathways linked to fibrosis, abnormal vascular remodeling, and bile duct injuries. By integrating their findings with clinical data, the researchers were able to establish connections between severe COVID-19 and long-term liver dysfunction.
 
Key Findings of the Study
-Liver Cells Infected with SARS-CoV-2 Show Similarities to Lung Cells
One of the most significant discoveries was that hepatocytes, the primary functional cells of the liver, in COVID-19 patients exhibited an expression profile similar to infected lung epithelial cells. This suggests that the virus directly affects liver cells, possibly leading to liver-specific complications similar to those seen in the lungs.
 
-Activation of Fibrotic Pathways and Liver Scarring
The study revealed extensive activation of fibrosis-related pathways in COVID-19 livers. Fibrosis is the thickening or scarring of tissue, and in this context, it suggests that the virus may contribute to chronic liver damage. The researchers identified the TGF-β (Transforming Growth Factor Beta), PDGF (Platelet-Derived Growth Factor), and VEGF (Vascular Endothelial Growth Factor) signaling pathways as key drivers of this fibrosis. These pathways are known to p lay critical roles in liver scarring, and their activation raises concerns about long-term complications such as liver fibrosis and cirrhosis in recovered COVID-19 patients.
 
-Vascular Damage and Cholangiopathy
Another crucial finding was the extensive damage to the liver’s vascular system. Even in cases where patients did not exhibit clinical symptoms of acute liver injury, the endothelial cells (which line the liver’s blood vessels) were found to be significantly altered. This could explain why some recovered COVID-19 patients experience persistent liver function abnormalities.
 
Additionally, researchers found strong evidence of cholangiopathy, a disease affecting the bile ducts. This was observed through increased proliferation of reactive cholangiocytes, which are cells lining the bile ducts. The excessive growth and activation of these cells can lead to bile duct scarring, a condition that, in severe cases, may necessitate liver transplantation.
 
Kupffer Cell Proliferation and Erythrocyte Precursors in the Liver
Kupffer cells, which are specialized immune cells in the liver, were found to be highly proliferative in COVID-19 patients. This suggests a heightened immune response, possibly in reaction to the viral infection. However, prolonged immune activation can also contribute to tissue damage and fibrosis. Additionally, the presence of erythrocyte progenitors (immature red blood cells) in the liver was an unexpected finding, as these cells are not typically seen in adult livers. Their presence suggests that COVID-19 may trigger abnormal hematopoietic (blood-forming) activity in the liver.
 
What Do These Findings Mean for Patients
The findings of this study raise important concerns about the potential long-term impact of COVID-19 on liver health. Even in patients who do not develop severe liver-related symptoms during their infection, these cellular changes suggest that subclinical damage may be occurring. Over time, such damage could contribute to chronic liver disease, increasing the risk of fibrosis, cirrhosis, and bile duct complications.
 
Doctors and healthcare professionals should be aware of these findings when monitoring COVID-19 survivors, particularly those who had severe cases of the disease. Regular liver function tests and imaging studies may be necessary for patients recovering from COVID-19, especially if they have preexisting liver conditions.
 
Potential for Future Treatments and Research Directions
This study not only enhances our understanding of how COVID-19 affects the liver but also opens new avenues for treatment strategies. The identification of key molecular pathways involved in liver fibrosis and vascular damage suggests potential therapeutic targets. Drugs that inhibit TGF-β, PDGF, and VEGF signaling, for instance, could help prevent or mitigate fibrosis in COVID-19 patients.
 
Further research is needed to determine whether these liver changes are reversible or if they lead to permanent damage. Long-term follow-up studies on recovered patients will be crucial in assessing the true extent of COVID-19’s impact on liver function. Additionally, future studies should explore whether patients with mild or moderate COVID-19 also experience similar liver changes, albeit at a lower intensity.
 
Conclusion
The study provides compelling evidence that COVID-19 significantly alters liver function at a cellular level. The virus was found to infect hepatocytes, triggering changes similar to those seen in lung epithelial cells. Additionally, the study identified extensive fibrosis-related activation, vascular damage, and bile duct abnormalities, all of which could contribute to long-term liver complications. Kupffer cell proliferation and the presence of erythrocyte progenitors further highlight the unexpected immune and hematopoietic changes associated with the disease.
 
While more research is needed to understand the full implications of these findings, this study underscores the importance of ongoing liver health monitoring for COVID-19 survivors. Healthcare providers should be vigilant in assessing potential liver complications, even in patients who appear to have recovered fully from the infection. Identifying those at risk early could help in preventing severe liver conditions and improving long-term health outcomes for COVID-19 survivors.
 
The study findings were published in the peer-reviewed journal: Genome Biology.
https://link.springer.com/article/10.1186/s13059-025-03499-5
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/breaking-study-finds-that-covid-19-accelerates-liver-cancer-growth-and-spread-via-exosomes-derived-from-syncytia
 
https://www.thailandmedical.news/news/sars-cov-2-spike-protein-interacts-with-12-liver-proteins-reactivates-hbv-and-activates-pre-cancerous-pathways
 
https://www.thailandmedical.news/news/covid-19-worsens-existing-liver-disease-and-could-spur-liver-cancer-development
 
https://www.thailandmedical.news/pages/usa_doctors_listings